The Therapeutic Proteins and Oral Vaccines Market Size is valued at 239.91 Million in 2023 and is predicted to reach 436.26 Million by the year 2031 at a 8.1 % CAGR during the forecast period for 2024-2031.
Key Industry Insights & Findings from the Report:
Therapeutic proteins are genetically engineered proteins that have a wide range of treatment applications. Therapeutic proteins are mainly prepared for pharmaceutical use. Oral vaccines are biologically prepared products, which are used in treating or preventing various infectious diseases. The increasing number of pharmaceutical drug developments or innovations is expected to drive the growth of the therapeutic protein and oral vaccine market in the near future.
Major driving factors of the therapeutic proteins and oral vaccines market are the increasing need for therapeutic proteins and oral vaccines, high prevalence of cancer diseases, rising number of clinical trials, increasing investments by key players for the development of promising therapies. Furthermore, advanced medical technologies, growth in the population, and a growing number of health-conscious people are enhancing the growth of the therapeutic proteins and oral vaccines market. However, the high price of devices, complex procedures, lack of strict government laws are restraining the growth of this market.
The therapeutic proteins and oral vaccines market is segmented into Drug Class, Distribution Channels, Applications, and regions. The Drug Class segment is further bifurcated into Therapeutic Proteins and Oral Vaccines. Therapeutic Proteins are subdivided into Therapeutic Proteins, Growth Factors, Fusion Proteins, Monoclonal Antibodies, Hormones, Coagulation Factors, and Other Therapeutic Proteins. While, Oral Vaccines are subdivided into Live Attenuated Vaccine, Inactivated Vaccine, Recombinant Vaccine, and Other Oral Vaccines. In the coming future, therapeutic proteins will be in high scope due to their effective and fast results and rise in therapy innovations. By Distribution Channels, the market is segmented into Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies. Hospital Pharmacies will upscale the market of therapeutic proteins and oral vaccines over the forecast period. In terms of Applications, the market can be divided into Oncology, Hematology, Immunology, Endocrinology, Infectious Disease, Cardiovascular Disease, and Other Applications. Oncology and Infectious diseases are the fastest-growing segments of this market due to the increasing prevalence of cancer and infectious diseases. Based on the region, the therapeutic proteins and oral vaccines market is divided into North America, Europe, Asia-Pacific, Latin America, and the Middle East and Africa. North America followed by Europe holds the maximum share of this market due to increased research and development expenditure, presence of significant market players and fast adaption of advanced technologies.
| Report Attribute | Specifications |
| Market Size Value In 2023 | USD 239.91 Million |
| Revenue Forecast In 2031 | USD 436.26 Million |
| Growth Rate CAGR | CAGR of 8.1 % from 2024 to 2031 |
| Quantitative Units | Representation of revenue in US$ Million and CAGR from 2024 to 2031 |
| Historic Year | 2019 to 2023 |
| Forecast Year | 2024-2031 |
| Report Coverage | The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends |
| Segments Covered | By Drug Class, By Distribution Channel, By Application |
| Regional Scope | North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
| Country Scope | U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico ;The UK; France; Italy; Spain; China; Japan; India; South Korea; South East Asia; South Korea; South East Asia |
| Competitive Landscape | Abbott Laboratories, Amgen, Inc., Biogen, Inc., Eily, Lilly, and Company, F. Hoffmann-La Roche, Johnson and Johnson, Merck & Co., Novo Nordisk, Pfizer, Inc., Sanofi S.A., Serum Institute of India Pvt. Ltd., Emergent Biosolutions Inc., TransAlgae, MigVax Ltd, Lumen Bioscience, Inc., and Other Prominent Players. |
| Customization Scope | Free customization report with the procurement of the report, Modifications to the regional and segment scope. Particular Geographic competitive landscape. |
| Pricing And Available Payment Methods | Explore pricing alternatives that are customized to your particular study requirements. |
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Therapeutic Proteins and Oral Vaccines Market Snapshot
Chapter 4. Global Therapeutic Proteins and Oral Vaccines Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis – Porter’s Five Forces Analysis
4.7. Competitive Landscape & Market Share Analysis
4.8. Impact of Covid-19 Analysis
Chapter 5. Market Segmentation 1: By Drug Class, Estimates & Trend Analysis
5.1. By Drug Class, & Market Share, 2019 & 2031
5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2019 to 2031 for the following By Drug Class:
5.2.1. Therapeutic Proteins
5.2.1.1. Growth Factors
5.2.1.2. Fusion Proteins
5.2.1.3. Monoclonal Antibodies
5.2.1.4. Hormones
5.2.1.5. Coagulation Factors
5.2.1.6. Other Therapeutic Proteins
5.2.2. Oral Vaccines
5.2.2.1. Live Attenuated Vaccine
5.2.2.2. Inactivated Vaccine
5.2.2.3. Recombinant Vaccine
5.2.2.4. Other Oral Vaccines
Chapter 6. Market Segmentation 1: By Distribution Channels Estimates & Trend Analysis
6.1. By Distribution Channels & Market Share, 2019 & 2031
6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2019 to 2031 for the following By Distribution Channels:
6.2.1. Hospital Pharmacies
6.2.2. Retail Pharmacies
6.2.3. Online Pharmacies
Chapter 7. Market Segmentation 1: By Applications Estimates & Trend Analysis
7.1. By Applications & Market Share, 2019 & 2031
7.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2019 to 2031 for the following By Applications:
7.2.1. Oncology
7.2.2. Hematology
7.2.3. Immunology
7.2.4. Endocrinology
7.2.5. Infectious Disease
7.2.6. Cardiovascular Disease
7.2.7. Other Applications
Chapter 8. Therapeutic Proteins and Oral Vaccines Market Segmentation 3: Regional Estimates & Trend Analysis
8.1. North America
8.1.1. North America Therapeutic Proteins and Oral Vaccines Market revenue (US$ Million) estimates and forecasts By Drug Class, 2024-2031
8.1.2. North America Therapeutic Proteins and Oral Vaccines Market revenue (US$ Million) estimates and forecasts By Distribution Channels, 2024-2031
8.1.3. North America Therapeutic Proteins and Oral Vaccines Market revenue (US$ Million) estimates and forecasts By Applications, 2024-2031
8.1.4. North America Therapeutic Proteins and Oral Vaccines Market revenue (US$ Million) estimates and forecasts by country, 2024-2031
8.2. Europe
8.2.1. Europe Therapeutic Proteins and Oral Vaccines Market revenue (US$ Million) By Drug Class, 2024-2031
8.2.2. Europe Therapeutic Proteins and Oral Vaccines Market revenue (US$ Million) By Distribution Channels, 2024-2031
8.2.3. Europe Therapeutic Proteins and Oral Vaccines Market revenue (US$ Million) By Applications, 2024-2031
8.2.4. Europe Therapeutic Proteins and Oral Vaccines Market revenue (US$ Million) by country, 2024-2031
8.3. Asia Pacific
8.3.1. Asia Pacific Therapeutic Proteins and Oral Vaccines Market revenue (US$ Million) By Drug Class, 2024-2031
8.3.2. Asia Pacific Therapeutic Proteins and Oral Vaccines Market revenue (US$ Million) By Distribution Channels, 2024-2031
8.3.3. Asia Pacific Therapeutic Proteins and Oral Vaccines Market revenue (US$ Million) By Applications, 2024-2031
8.3.4. Asia Pacific Therapeutic Proteins and Oral Vaccines Market revenue (US$ Million) by country, 2024-2031
8.4. Latin America
8.4.1. Latin America Therapeutic Proteins and Oral Vaccines Market revenue (US$ Million) By Drug Class, (US$ Million) 2024-2031
8.4.2. Latin America Therapeutic Proteins and Oral Vaccines Market revenue (US$ Million) By Distribution Channels, (US$ Million) 2024-2031
8.4.3. Latin America Therapeutic Proteins and Oral Vaccines Market revenue (US$ Million) By Applications, (US$ Million) 2024-2031
8.4.4. Latin America Therapeutic Proteins and Oral Vaccines Market revenue (US$ Million) by country, (US$ Million) 2024-2031
8.5. Middle East & Africa
8.5.1. Middle East & Africa Therapeutic Proteins and Oral Vaccines Market revenue (US$ Million) By Drug Class, (US$ Million) 2024-2031
8.5.2. Middle East & Africa Therapeutic Proteins and Oral Vaccines Market revenue (US$ Million) By Distribution Channels, (US$ Million) 2024-2031
8.5.3. Middle East & Africa Therapeutic Proteins and Oral Vaccines Market revenue (US$ Million) By Applications, (US$ Million) 2024-2031
8.5.4. Middle East & Africa Therapeutic Proteins and Oral Vaccines Market revenue (US$ Million) by country, (US$ Million) 2024-2031
Chapter 9. Competitive Landscape
9.1. Major Mergers and Acquisitions/Strategic Alliances
9.2. Company Profiles
9.2.1. Abbott Laboratories
9.2.2. Amgen, Inc.
9.2.3. Biogen, Inc.
9.2.4. Eily, Lilly, and Company
9.2.5. F. Hoffmann-La Roche
9.2.6. Johnson and Johnson
9.2.7. Merck & Co.
9.2.8. Novo Nordisk
9.2.9. Pfizer, Inc.
9.2.10. Sanofi S.A.
9.2.11. Serum Institute of India Pvt. Ltd.
9.2.12. Emergent Biosolutions Inc.
9.2.13. TransAlgae
9.2.14. MigVax Ltd
9.2.15. Lumen Bioscience, Inc.
9.2.16. Neurelis, Inc.
9.2.17. Other Prominent Player
Global Therapeutic Proteins and Oral Vaccines Market Size (Value US$ Mn) & Forecasts and Trend Analyses, Based on Drug Class
Global Therapeutic Proteins and Oral Vaccines Market Size (Value US$ Mn) & Forecasts and Trend Analyses, Based on Distribution Channels
Global Therapeutic Proteins and Oral Vaccines Market Size (Value US$ Mn) & Forecasts and Trend Analyses, Based on Applications
Global Therapeutic Proteins and Oral Vaccines Market Size (Value US$ Mn) & Forecasts and Trend Analyses, Based on Region
North America Therapeutic Proteins and Oral Vaccines Market Revenue (US$ Million) By Country,
Europe Therapeutic Proteins and Oral Vaccines Market Revenue (US$ Million) By Country,
Asia Pacific Therapeutic Proteins and Oral Vaccines Market Revenue (US$ Million) By Country,
Latin America Therapeutic Proteins and Oral Vaccines Market Revenue (US$ Million) By Country,
Middle East & Africa Therapeutic Proteins and Oral Vaccines Market Revenue (US$ Million) By Country,